Co-Diagnostics Inc
NASDAQ: CODX
$1.01
-$0.01 (-0.5%)
Real Time Data Delayed 15 Min.
CODX Stock Chart and Intraday Price
CODX Stock Data
| Asset Type | Common Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Address | 4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY, UT, US |
| Fiscal Year End | December |
| Latest Quarter | 2023-12-31 |
| Market Cap | 35.95M USD |
| Shares Outstanding | 31,259,700 |
CODX Articles
Wednesday afternoon's top analyst upgrades and downgrades included Inovio Pharmaceuticals, McDonald’s, Orchard Therapeutics, VBI Vaccines and Wingstop.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including Co-Diagnostics, DocuSign, Dow, Nomura, Sea and more.
Published:
Tuesday's top analyst upgrades and downgrades included AECOM, BBVA, Cheniere Energy, Chevron, DraftKings, General Motors, Moderna, Novavax, Palo Alto Networks and Penn National Gaming.
Published:
Co-Diagnostics announced Tuesday that it has entered into an agreement with Arches Research to expand Arches' COVID-19 testing services using Co-Diagnostics’ test kit.
Published:
Friday's top analyst upgrades and downgrades included AES, Applied Materials, Bloom Energy, Chimera Investment, Co-Diagnostics, FirstEnergy, Home Depot, Marriott, Target, Tesla and Walmart.
Published:
Last Updated:
Investors look at Aytu BioScience as it looks at expanding in the COVID testing field.
Published:
Aytu BioScience has a distribution agreement for a COVID-19 rapid test and is developing a potential UV light-based treatment.
Published:
Wednesday's top analyst upgrades and downgrades included AbbVie, American Electric Power, Anheuser-Busch InBev, Arconic, Baidu, Best Buy, Co-Diagnostics, Cree, Exelon, Home Depot, NRG Energy,...
Published:
Monday's top analyst upgrades and downgrades included Apple, Best Buy, Cinemark, Co-Diagnostics, DraftKings, Energizer, Novavax, Nvidia, Palo Alto Networks and Petrobras.
Published:
This specialty pharmaceutical company is making good progress on multiple fronts, including changes to its board of directors and with its test for and treatment of COVID-19.
Published:
Aytu BioScience has been one of the biggest winners in the fight against the novel coronavirus. The company is sending 2,700 COVID-19 rapid tests to Denver for use with first responders.
Published:
Co-Diagnostics has been the toast of Wall Street after it went from penny stock status to a revered coronavirus testing stock.
Published:
GenMark Diagnostics shares shot up early on Wednesday after the company provided an update on its quarterly numbers and where it stands with its coronavirus test.
Published:
Co-Diagnostics shares popped on Monday after the company announced a key update from the FDA on its COVID-19 test kit.
Published:
Becton, Dickinson is officially throwing its hat in the ring to fight COVID-19. Specifically, this firm is working on the front end by testing for the disease and antibodies that have been built up...
Published: